1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Intravenous Immunoglobulin Market – By Type

1.3.2        Intravenous Immunoglobulin Market – By Application

1.3.3        Intravenous Immunoglobulin Market – By Distribution Channel

1.3.4        Intravenous Immunoglobulin Market – By End User

1.3.5        Intravenous Immunoglobulin Market – By Country

2.           Intravenous Immunoglobulin Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Intravenous Immunoglobulin Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        US – PEST Analysis

4.3         Expert Opinion

4.4         Pipeline Product

5.           United States Intravenous Immunoglobulin Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Immunodeficiency Disease Prevalence

5.1.2        Increasing Geriatric Population

5.2         Market Restraints

5.2.1        Adverse Effects of Immunoglobulin Therapy

5.3         Market Opportunities

5.3.1        Flourishing Pharmaceutical Industry

5.4         Future Trends

5.4.1        Strong Pipeline of IVIG Candidates

5.5         Impact Analysis

6.           Intravenous Immunoglobulin Market – US Analysis

6.1         United States Intravenous Immunoglobulin Market Revenue Forecast and Analysis

6.2         Market Positioning of Key Players

7.           United States Intravenous Immunoglobulin Market Analysis – by Type

7.1         Overview

7.2         United States Intravenous Immunoglobulin Market, by Type – Volume and Forecast to 2028 (Metric Tons)

7.3         United States Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)

7.4         IgG

7.4.1        Overview

7.4.2        IgG: United States Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5         IgM

7.5.1        Overview

7.5.2        IgM: United States Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6         IgA

7.6.1        Overview

7.6.2        IgA: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

7.7         Others

7.7.1        Overview

7.7.2        Others: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

8.           United States Intravenous Immunoglobulin Market Analysis – by Application

8.1         Overview

8.2         United States Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

8.3         Hypogammaglobulinemia

8.3.1        Overview

8.3.2        Hypogammaglobulinemia: Intravenous Immunoglobulin Market– Revenue and Forecast to 2028 (US$ Million)

8.4         Chronic Inflammatory Demyelinating Polyneuropathy (CIPD)

8.4.1        Overview

8.4.2        CIPD: Intravenous Immunoglobulin Market– Revenue and Forecast to 2028 (US$ Million)

8.5         Immunodeficiency Diseases

8.5.1        Overview

8.5.2        Immunodeficiency Disease: Intravenous Immunoglobulin Market– Revenue and Forecast to 2028 (US$ Million)

8.6         Myasthenia Gravis

8.6.1        Overview

8.6.2        Myasthenia Gravis: Intravenous Immunoglobulin Market– Revenue and Forecast to 2028 (US$ Million)

8.7         Multifocal Motor Neuropathy

8.7.1        Overview

8.7.2        Multifocal Motor Neuropathy: Intravenous Immunoglobulin Market– Revenue and Forecast to 2028 (US$ Million)

8.8         Idiopathic Thrombocytopenic Purpura

8.8.1        Overview

8.8.2        Idiopathic Thrombocytopenic Purpura: Intravenous Immunoglobulin Market– Revenue and Forecast to 2028 (US$ Million)

8.9         Inflammatory Myopathies

8.9.1        Overview

8.9.2        Inflammatory Myopathies: United States Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)

8.10      Specific Antibody Deficiency

8.10.1     Overview

8.10.2     Specific Antibody Deficiency: United States Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)

8.11      Guillain-Barre Syndrome

8.11.1     Overview

8.11.2     Guillain-Barre Syndrome: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

8.12      Others

8.12.1     Overview

8.12.2     Others: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

9.           United States Intravenous Immunoglobulin Market Analysis – by Distribution Channel

9.1         Overview

9.2         United States Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

9.3         Hospital Pharmacy

9.3.1        Overview

9.3.2        Hospital Pharmacy: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Retail Pharmacy

9.4.1        Overview

9.4.2        Retail Pharmacy: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Others

9.5.1        Overview

9.5.2        Others: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

10.        United States Intravenous Immunoglobulin Market Analysis – by End User

10.1      Overview

10.2      United States Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Specialty Clinics

10.4.1     Overview

10.4.2     Specialty Clinics: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Others

10.5.1     Overview

10.5.2     Others: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

11.        United States Intravenous Immunoglobulin Market: Impact Assessment of COVID-19 Pandemic

11.1      US: Impact Assessment of COVID-19 Pandemic

12.        US Intravenous Immunoglobulin Market – Industry Landscape

12.1      Overview

12.2      Growth Strategies in US Intravenous Immunoglobulin Market (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      Takeda Pharmaceutical Co Ltd

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Grifols SA

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Pfizer Inc

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      ADMA Biologics, Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Bio Products Laboratory Ltd.

13.5.1.1.1       Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Octapharma AG

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Kedrion SpA

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      CSL Ltd

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      LFB Group

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Prothya Biosolutions B.V.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Pipeline Product Developments in the US Intravenous Immunoglobulin Market

Table 2.             R&D Investments by Major Pharmaceuticals Companies in US

Table 3.             United States Intravenous Immunoglobulin Market, by Type – Volume and Forecast to 2028 (Metric Tons)

Table 4.             United States Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 5.             United States Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 6.             United States Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 7.             United States Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Organic Developments in the US Intravenous Immunoglobulin Market

Table 9.             Inorganic Developments in the US Intravenous Immunoglobulin Market

Table 10.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Intravenous Immunoglobulin Market Segmentation

Figure 2.           United States Intravenous Immunoglobulin Market Overview

Figure 3.           IgG Held Largest Share of Intravenous Immunoglobulin Market

Figure 4.           United States Intravenous Immunoglobulin Market, Industry Landscape

Figure 5.           US PEST Analysis

Figure 6.           Expert Opinion

Figure 7.           US Intravenous Immunoglobulin Market Impact Analysis of Drivers and Restraints

Figure 8.           United States Intravenous Immunoglobulin Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Market Positioning of Key Players in United States Intravenous Immunoglobulin Market

Figure 10.        United States Intravenous Immunoglobulin Market, by Type, 2022 & 2028 (%)

Figure 11.        IgG: United States Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        IgM: United States Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        IgA: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Others: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        United States Intravenous Immunoglobulin Market, by Application, 2022 & 2028 (%)

Figure 16.        Hypogammaglobulinemia: Intravenous Immunoglobulin Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        CIPD: Intravenous Immunoglobulin Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Immunodeficiency Disease: Intravenous Immunoglobulin Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Myasthenia Gravis: Intravenous Immunoglobulin Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Multifocal Motor Neuropathy: Intravenous Immunoglobulin Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Idiopathic Thrombocytopenic Purpura: Intravenous Immunoglobulin Market– Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Inflammatory Myopathies: United States Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Specific Antibody Deficiency: United States Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Guillain-Barre Syndrome: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Others: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        United States Intravenous Immunoglobulin Market, by Distribution Channel, 2022 & 2028 (%)

Figure 27.        Hospital Pharmacy: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Retail Pharmacy: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Others: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        United States Intravenous Immunoglobulin Market, by End User, 2022 & 2028 (%)

Figure 31.        Hospitals: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Specialty Clinics: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Others: United States Intravenous Immunoglobulins Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Impact of COVID-19 Pandemic on US Intravenous Immunoglobulin Market

Figure 35.        Growth Strategies in US Intravenous Immunoglobulin Market (%)